Leucettinib-21 (LCTB-21)

Chemical Structure : Leucettinib-21

加入收藏

货号: PC-21506Not For Human Use, Lab Use Only.

Leucettinib-21 is a potent, selective DYRKs and CLKs kinases with IC50 of 2.4, 6.7, 12, 33, and 5 nM for DYRK1A, DYRK1B, CLK1, CLK2, and CLK4, respectively.

规格	价格	库存	数量
50 mg		Get quote
100 mg		Get quote
200 mg		Get quote

获取报价单

* 请选择数量再加入购物车

or Bulk Inquiry

大包装，大折扣！

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

生物&药学活性

Leucettinib-21 (LCTB-21) is a potent, selective DYRKs and CLKs kinases with IC50 of 2.4, 6.7, 12, 33, and 5 nM for DYRK1A, DYRK1B, CLK1, CLK2, and CLK4, respectively.
Leucettinib-21 weakly inhibits DYRK2/3/4, and CLK3 (IC50=200-1000 nM), inhibits only weakly inhibits some kinases (RPS6KA4, CDK7, DMPK) in a panel of 468 kinases at 1 uM.
Leucettinib-21 shows Kd values of 0.272 and 0.388 nM for DYRK1A and CLK1, respectively, 26 and 22 times lower than that for Leucettine L41 (Cat#PC-61025).
Leucettinib-21 triggers a dose-dependent inhibition of endogenous DYRK1A catalytic activity in HT-22 mouse hippocampal neuronal cells with IC50 of 36 nM.
Leucettinib-21 (0-10 uM) inhibits the phosphorylation of reported DYRK1A substrate sites in SH-SY5Y cells, such as Thr286-cyclin D1 and Thr212-Tau, protects cyclin D1 from proteolytic degradation, leading to its accumulation.
Leucettinib-21 (0.4 mg/kg, oral gavage daily, 10 days) corrects memory disorders in the Down syndrome mouse model Ts65Dn, a classical animal model of Down syndrome (DS).

物理化学性质&存储条件

分子量	358.46
分子式	C18H22N4O2S
外观性状	Solid
CAS No.
储存条件	固体粉末 -20°C 12 个月; 4°C 6 个月	配置液 -80°C 6 个月; -20°C 6 个月
Shipping
Solubility	10 mM in DMSO
Chemical Name/SMILES	(R,Z)-5-(benzo[d]thiazol-6-ylmethylene)-2-((1-methoxy-4-methylpentan-2-yl)amino)-3,5-dihydro-4H-imidazol-4-one

参考文献

1. Lindberg MF, et al. J Med Chem. 2023 Mar 23;66(6):4106-4130.